There is a new wave of psychedelic treatment moving through clinical trials targeting mental health conditions, and they are showing strong efficacy. Ben Hargreaves finds that certain treatments ...

GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD), sending its shares soaring and prompting a $150 million offering to ...

CHEGA is delighting in a court ‘victory’ today which means its election posters, associating both the prime minister, and the leader of the Socialist party, with ‘faces of corruption’ over the last 50 ...